1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine

C220H435F2N43O — CID 163882658

IUPAC1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine
SMILESCC(C)N1CCC(N2CCC(F)(F)CC2)CC1.CC(C)N1CCC(N2CCC(N3CCN(C)CC3)CC2)CC1.CC(C)N1CCC(N2CCC(N3CCOCC3)CC2)CC1.CC(C)N1CCC(N2CCC3(CC2)CC3)CC1.CC(C)N1CCC(N2CCCN(C3CC3)CC2)CC1.CC(C)N1CCC(N2CCN(C3CCN(C)CC3)CC2)CC1.CC(C)N1CCC(N2CCN(CCN(C)C)CC2)CC1.CC(C)N1CCC(N2CCN3CCCC3C2)CC1.CC(C)N1CCC(NC2CCN(C(C)C)CC2)CC1.CCCN1CCN(C2CCN(C(C)C)CC2)CC1.CCN1C(C)CN(C2CCN(C(C)C)CC2)CC1C.CCN1C2CC1CN(C1CCN(C(C)C)CC1)C2.CCN1CC2CC(C1)N2C1CCN(C(C)C)CC1.CCN1CC2CC1CN2C1CCN(C(C)C)CC1
InChIInChI=1S/2C18H36N4.C17H33N3O.C16H34N4.C16H31N3.2C16H33N3.4C15H29N3.C15H31N3.C15H28N2.C13H24F2N2/c1-16(2)20-8-4-17(5-9-20)21-10-6-18(7-11-21)22-14-12-19(3)13-15-22;1-16(2)20-10-6-18(7-11-20)22-14-12-21(13-15-22)17-4-8-19(3)9-5-17;1-15(2)18-7-3-16(4-8-18)19-9-5-17(6-10-19)20-11-13-21-14-12-20;1-15(2)19-7-5-16(6-8-19)20-13-11-18(12-14-20)10-9-17(3)4;1-14(2)17-10-6-16(7-11-17)19-9-3-8-18(12-13-19)15-4-5-15;1-13(2)18-9-5-15(6-10-18)17-16-7-11-19(12-8-16)14(3)4;1-6-19-14(4)11-18(12-15(19)5)16-7-9-17(10-8-16)13(2)3;1-13(2)16-8-5-14(6-9-16)18-11-10-17-7-3-4-15(17)12-18;1-4-16-10-15-9-14(16)11-18(15)13-5-7-17(8-6-13)12(2)3;1-4-18-14-9-15(18)11-17(10-14)13-5-7-16(8-6-13)12(2)3;1-4-16-10-14-9-15(11-16)18(14)13-5-7-17(8-6-13)12(2)3;1-4-7-16-10-12-18(13-11-16)15-5-8-17(9-6-15)14(2)3;1-13(2)16-9-3-14(4-10-16)17-11-7-15(5-6-15)8-12-17;1-11(2)16-7-3-12(4-8-16)17-9-5-13(14,15)6-10-17/h2*16-18H,4-15H2,1-3H3;15-17H,3-14H2,1-2H3;15-16H,5-14H2,1-4H3;14-16H,3-13H2,1-2H3;13-17H,5-12H2,1-4H3;13-16H,6-12H2,1-5H3;13-15H,3-12H2,1-2H3;3*12-15H,4-11H2,1-3H3;14-15H,4-13H2,1-3H3;13-14H,3-12H2,1-2H3;11-12H,3-10H2,1-2H3
InChIKeyPUPQULLHWDBUPS-UHFFFAOYSA-N
MW3737.20 g/mol
LogP26.23
Rot. Bonds43

About 1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine

1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine (PubChem CID 163882658) has the molecular formula C220H435F2N43O and a molecular weight of 3737.20 g/mol. Its IUPAC name is 1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine.

Molecular Properties

Compound Name1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine
PubChem CID163882658
Molecular FormulaC220H435F2N43O
Molecular Weight3737.20 g/mol
Exact Mass3734.53
IUPAC Name1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine
SMILESCC(C)N1CCC(N2CCC(F)(F)CC2)CC1.CC(C)N1CCC(N2CCC(N3CCN(C)CC3)CC2)CC1.CC(C)N1CCC(N2CCC(N3CCOCC3)CC2)CC1.CC(C)N1CCC(N2CCC3(CC2)CC3)CC1.CC(C)N1CCC(N2CCCN(C3CC3)CC2)CC1.CC(C)N1CCC(N2CCN(C3CCN(C)CC3)CC2)CC1.CC(C)N1CCC(N2CCN(CCN(C)C)CC2)CC1.CC(C)N1CCC(N2CCN3CCCC3C2)CC1.CC(C)N1CCC(NC2CCN(C(C)C)CC2)CC1.CCCN1CCN(C2CCN(C(C)C)CC2)CC1.CCN1C(C)CN(C2CCN(C(C)C)CC2)CC1C.CCN1C2CC1CN(C1CCN(C(C)C)CC1)C2.CCN1CC2CC(C1)N2C1CCN(C(C)C)CC1.CCN1CC2CC1CN2C1CCN(C(C)C)CC1
InChIInChI=1S/2C18H36N4.C17H33N3O.C16H34N4.C16H31N3.2C16H33N3.4C15H29N3.C15H31N3.C15H28N2.C13H24F2N2/c1-16(2)20-8-4-17(5-9-20)21-10-6-18(7-11-21)22-14-12-19(3)13-15-22;1-16(2)20-10-6-18(7-11-20)22-14-12-21(13-15-22)17-4-8-19(3)9-5-17;1-15(2)18-7-3-16(4-8-18)19-9-5-17(6-10-19)20-11-13-21-14-12-20;1-15(2)19-7-5-16(6-8-19)20-13-11-18(12-14-20)10-9-17(3)4;1-14(2)17-10-6-16(7-11-17)19-9-3-8-18(12-13-19)15-4-5-15;1-13(2)18-9-5-15(6-10-18)17-16-7-11-19(12-8-16)14(3)4;1-6-19-14(4)11-18(12-15(19)5)16-7-9-17(10-8-16)13(2)3;1-13(2)16-8-5-14(6-9-16)18-11-10-17-7-3-4-15(17)12-18;1-4-16-10-15-9-14(16)11-18(15)13-5-7-17(8-6-13)12(2)3;1-4-18-14-9-15(18)11-17(10-14)13-5-7-16(8-6-13)12(2)3;1-4-16-10-14-9-15(11-16)18(14)13-5-7-17(8-6-13)12(2)3;1-4-7-16-10-12-18(13-11-16)15-5-8-17(9-6-15)14(2)3;1-13(2)16-9-3-14(4-10-16)17-11-7-15(5-6-15)8-12-17;1-11(2)16-7-3-12(4-8-16)17-9-5-13(14,15)6-10-17/h2*16-18H,4-15H2,1-3H3;15-17H,3-14H2,1-2H3;15-16H,5-14H2,1-4H3;14-16H,3-13H2,1-2H3;13-17H,5-12H2,1-4H3;13-16H,6-12H2,1-5H3;13-15H,3-12H2,1-2H3;3*12-15H,4-11H2,1-3H3;14-15H,4-13H2,1-3H3;13-14H,3-12H2,1-2H3;11-12H,3-10H2,1-2H3
InChIKeyPUPQULLHWDBUPS-UHFFFAOYSA-N
XLogP26.23
TPSA157.34 Ų
H-Bond Donors1
H-Bond Acceptors44
Rotatable Bonds43
Heavy Atoms266
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003737.20
LogP ≤ 526.23
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1044

Analyze 1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine?
The IUPAC name of 1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine (CID 163882658) is 1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine.
What is the SMILES notation for 1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine?
The canonical SMILES for 1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine is CC(C)N1CCC(N2CCC(F)(F)CC2)CC1.CC(C)N1CCC(N2CCC(N3CCN(C)CC3)CC2)CC1.CC(C)N1CCC(N2CCC(N3CCOCC3)CC2)CC1.CC(C)N1CCC(N2CCC3(CC2)CC3)CC1.CC(C)N1CCC(N2CCCN(C3CC3)CC2)CC1.CC(C)N1CCC(N2CCN(C3CCN(C)CC3)CC2)CC1.CC(C)N1CCC(N2CCN(CCN(C)C)CC2)CC1.CC(C)N1CCC(N2CCN3CCCC3C2)CC1.CC(C)N1CCC(NC2CCN(C(C)C)CC2)CC1.CCCN1CCN(C2CCN(C(C)C)CC2)CC1.CCN1C(C)CN(C2CCN(C(C)C)CC2)CC1C.CCN1C2CC1CN(C1CCN(C(C)C)CC1)C2.CCN1CC2CC(C1)N2C1CCN(C(C)C)CC1.CCN1CC2CC1CN2C1CCN(C(C)C)CC1.
What is the InChIKey of 1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine?
The InChIKey is PUPQULLHWDBUPS-UHFFFAOYSA-N. The full InChI is InChI=1S/2C18H36N4.C17H33N3O.C16H34N4.C16H31N3.2C16H33N3.4C15H29N3.C15H31N3.C15H28N2.C13H24F2N2/c1-16(2)20-8-4-17(5-9-20)21-10-6-18(7-11-21)22-14-12-19(3)13-15-22;1-16(2)20-10-6-18(7-11-20)22-14-12-21(13-15-22)17-4-8-19(3)9-5-17;1-15(2)18-7-3-16(4-8-18)19-9-5-17(6-10-19)20-11-13-21-14-12-20;1-15(2)19-7-5-16(6-8-19)20-13-11-18(12-14-20)10-9-17(3)4;1-14(2)17-10-6-16(7-11-17)19-9-3-8-18(12-13-19)15-4-5-15;1-13(2)18-9-5-15(6-10-18)17-16-7-11-19(12-8-16)14(3)4;1-6-19-14(4)11-18(12-15(19)5)16-7-9-17(10-8-16)13(2)3;1-13(2)16-8-5-14(6-9-16)18-11-10-17-7-3-4-15(17)12-18;1-4-16-10-15-9-14(16)11-18(15)13-5-7-17(8-6-13)12(2)3;1-4-18-14-9-15(18)11-17(10-14)13-5-7-16(8-6-13)12(2)3;1-4-16-10-14-9-15(11-16)18(14)13-5-7-17(8-6-13)12(2)3;1-4-7-16-10-12-18(13-11-16)15-5-8-17(9-6-15)14(2)3;1-13(2)16-9-3-14(4-10-16)17-11-7-15(5-6-15)8-12-17;1-11(2)16-7-3-12(4-8-16)17-9-5-13(14,15)6-10-17/h2*16-18H,4-15H2,1-3H3;15-17H,3-14H2,1-2H3;15-16H,5-14H2,1-4H3;14-16H,3-13H2,1-2H3;13-17H,5-12H2,1-4H3;13-16H,6-12H2,1-5H3;13-15H,3-12H2,1-2H3;3*12-15H,4-11H2,1-3H3;14-15H,4-13H2,1-3H3;13-14H,3-12H2,1-2H3;11-12H,3-10H2,1-2H3.
What are the key properties of 1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine?
1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine has a molecular weight of 3737.20 g/mol, XLogP of 26.23, 43 rotatable bonds, 1 hydrogen bond donors, and 44 hydrogen bond acceptors.
Where does this data come from?
All data for 1-cyclopropyl-4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepane;4,4-difluoro-1-(1-propan-2-ylpiperidin-4-yl)piperidine;N,N-dimethyl-2-[4-(1-propan-2-ylpiperidin-4-yl)piperazin-1-yl]ethanamine;1-ethyl-2,6-dimethyl-4-(1-propan-2-ylpiperidin-4-yl)piperazine;2-ethyl-5-(1-propan-2-ylpiperidin-4-yl)-2,5-diazabicyclo[2.2.1]heptane;3-ethyl-6-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;6-ethyl-3-(1-propan-2-ylpiperidin-4-yl)-3,6-diazabicyclo[3.1.1]heptane;1-(1-methylpiperidin-4-yl)-4-(1-propan-2-ylpiperidin-4-yl)piperazine;1-methyl-4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]piperazine;2-(1-propan-2-ylpiperidin-4-yl)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine;6-(1-propan-2-ylpiperidin-4-yl)-6-azaspiro[2.5]octane;4-[1-(1-propan-2-ylpiperidin-4-yl)piperidin-4-yl]morpholine;1-(1-propan-2-ylpiperidin-4-yl)-4-propylpiperazine;1-propan-2-yl-N-(1-propan-2-ylpiperidin-4-yl)piperidin-4-amine is sourced from PubChem (CID 163882658), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).